Since all tested imidazoles which suppress testosterone production have as a common feature a phenylated side chain of the imidazole molecule, this indicates a structure/activity relationship for the effects observed. In vitro studies with mouse Leydig cells demonstrated a direct reversible inhibition of testosterone biosynthesis by ketoconazole. Testosterone therapy suppresses sperm production, sometimes to zero, within months. This guide breaks down exactly when therapy helps, how it’s diagnosed, the safest treatments, and how to monitor results with confidence. In vivo perfusion of canine testes with ketoconazole inhibited the stimulation of testosterone production by human chorionic gonadotropin in a dose-dependent manner. Can ketoconazole shampoo be used to treat fungal infections on other parts of the body? However, in the treatment of prostate cancer, concomitant glucocorticoid administration is needed to prevent adrenal insufficiency. It was speculated that antifungal properties of ketoconazole reduce scalp microflora and consequently may reduce follicular inflammation that contributes to alopecia. Ketoconazole shampoo in conjunction with an oral 5α-reductase inhibitor such as finasteride or dutasteride has been used off label to treat androgenic alopecia. Topically administered ketoconazole is usually prescribed for fungal infections of the skin and mucous membranes, such as athlete's foot, ringworm, candidiasis (yeast infection or thrush), jock itch, and tinea versicolor. Oral levoketoconazole may have a lower risk of liver toxicity than oral ketoconazole. Second, ketoconazole is an androgen receptor antagonist, competing with androgens such as testosterone and dihydrotestosterone (DHT) for binding to the androgen receptor. In the event of an overdose of oral ketoconazole, treatment should be supportive and based on symptoms. The side effects of ketoconazole are sometimes harnessed in the treatment of non-fungal conditions. Ketoconazole is used orally in dosages of 200 to 400 mg per day in the treatment of superficial and deep fungal infections. As with all azole antifungal agents, ketoconazole works principally by inhibiting the enzyme cytochrome P450 14α-demethylase (CYP51A1). A subsequent trial in Europe failed to show a risk to infants of mothers receiving ketoconazole. It should be used for the treatment of certain fungal infections, known as endemic mycoses, only when alternative antifungal therapies are not available or not tolerated. Oral ketoconazole at a dosage range of 400 to 2,000 mg/day has been found to result in a rate of gynecomastia of 21%. In any case, the risk of hepatotoxicity with ketoconazole limits its use in all of these indications, especially in those that are benign such as hirsutism. The hormonal effects were generally unrelated to duration of therapy, although there may have been partial reversal with continued therapy. An official website of the United States government While it might be used off-label for other fungal infections, it’s essential to consult with a doctor before using it on other areas of the body. Yes, 2% ketoconazole shampoo contains a higher concentration of the active ingredient and is generally more effective for treating severe cases of dandruff and seborrheic dermatitis. This action disrupts the integrity of the fungal cell, ultimately leading to its demise. Ketoconazole shampoo is a widely used antifungal medication primarily prescribed for treating scalp conditions like seborrheic dermatitis (dandruff) and tinea versicolor. What should I do if I experience side effects from ketoconazole shampoo? Paradoxically, ketoconazole shampoo is sometimes used to treat certain types of hair loss, as the anti-inflammatory effects on the scalp can sometimes improve hair growth. Ketoconazole appears to be the first example of a non-steroidal compound which binds competitively to both SSBG and multiple steroid hormone receptors, suggesting that the ligand binding sites of these proteins share some features in common. It should be noted, however, that the dose of ketoconazole required for 50% occupancy of the androgen receptor is not likely to be achieved in vivo, at least in plasma. Additional binding studies performed with ketoconazole in the presence of increasing amounts of 3HR1881 showed that the interaction of ketoconazole with AR was competitive when the data were analyzed by the Scatchard method.
